Your browser doesn't support javascript.
loading
Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma.
Bhattacharyya, Srirupa; Oblinger, Janet L; Beauchamp, Roberta L; Yin, Zhenzhen; Erdin, Serkan; Koundinya, Priya; Ware, Anna D; Ferrer, Marc; Jordan, Justin T; Plotkin, Scott R; Xu, Lei; Chang, Long-Sheng; Ramesh, Vijaya.
Afiliação
  • Bhattacharyya S; Department of Neurology and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Oblinger JL; Center for Childhood Cancer & Blood Diseases, Nationwide Children's Hospital and Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.
  • Beauchamp RL; Department of Neurology and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Yin Z; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Erdin S; Department of Neurology and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Koundinya P; Department of Neurology and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Ware AD; Department of Neurology and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Ferrer M; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
  • Jordan JT; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.
  • Plotkin SR; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.
  • Xu L; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Chang LS; Center for Childhood Cancer & Blood Diseases, Nationwide Children's Hospital and Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.
  • Ramesh V; Department of Neurology and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Neuro Oncol ; 25(9): 1617-1630, 2023 09 05.
Article em En | MEDLINE | ID: mdl-36806881

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neurofibromatose 2 / Neoplasias Meníngeas / Meningioma / Neurilemoma Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neurofibromatose 2 / Neoplasias Meníngeas / Meningioma / Neurilemoma Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido